Australia’s active vaccine safety system

  • HPV vaccine safety surveillance data

    From January 2018 a new HPV vaccine, Gardasil9®, is being funded under the National Immunisation Program. AusVaxSafety is monitoring the safety of HPV vaccine in 11- to 14-year olds. The current reported event rates are consistent with what are expected according to the existing data. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

     

     

    Last updated 13/12/19

    41,784 Parents/carers responded to an SMS about their child’s health a
    few days after their HPV vaccinations.

    91.2%
    reported no adverse events

    91.2%
    reported no adverse events


    8.8%
    reported any adverse
    event, including...


    0.6%
    who reported taking their child
    to a doctor or emergency
    department in the days after
    vaccination.

    The adverse events they reported were similar to the types of adverse events reported overall

     

    3,674 parents/carers reported one or more adverse events.
    The most commonly reported were:



    These symptoms are known to occur after vaccination. They are generally mild and short-lived.

  • Influenza vaccine safety surveillance data

    Surveillance of 2019 influenza vaccine safety commenced from 1 April 2019. The current reported event rates are consistent with what are expected according to the existing data. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

     

     

     

    Last updated 13/12/19

    37,710 Parents/carers responded to an SMS about their child’s health a
    few days after their influenza vaccinations.

    95%
    reported no adverse events

    95%
    reported no adverse events


    5%
    reported any adverse
    event, including...


    0.5%
    who reported taking their child
    to a doctor or emergency
    department in the days after
    vaccination.

    The adverse events they reported were similar to the types of adverse events reported overall

     

    1,903 parents/carers reported one or more adverse events.
    The most commonly reported were:



    These symptoms are known to occur after vaccination. They are generally mild and short-lived.

  • Meningococcal vaccine safety surveillance data

    Surveillance of 2019 Men ACWY vaccine safety commenced from 1 April 2019. The current reported event rates are consistent with existing data on Men ACWY vaccines and no safety signals have been detected. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

     

     

     

    Last updated 20/12/19

    6,506 Parents/carers responded to an SMS about their child’s health a
    few days after their MenACWY vaccinations.

    93.8%
    reported no adverse events

    93.8%
    reported no adverse events


    6.2%
    reported any adverse
    event, including...


    0.5%
    who reported taking their child
    to a doctor or emergency
    department in the days after
    vaccination.

    The adverse events they reported were similar to the types of adverse events reported overall

    404 parents/carers reported one or more adverse events.
    The most commonly reported were:



    These symptoms are known to occur after vaccination. They are generally mild and short-lived.